Arch Venture Corp »

Q32 Bio shares owned by Arch Venture Corp

Quarter-by-quarter ownership of Q32 Bio shares owned by Arch Venture Corp from 13F filings

Historical chart of Arch Venture Corp investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Arch Venture Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Arch Venture Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.5M 321k 17.04

More positions owned by Arch Venture Corp

Verve Therapeutics (VERV)
Erasca (ERAS)
Gossamer Bio (GOSS)
Denali Therapeutics (DNLI)
Q32 Bio
Cero Therapeutics Holdings Class A Com (CERO)
Singular Genomics Systems In (OMIC)
Unity Biotechnology (UBX)

View all positions for Arch Venture Corp

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
Vivo Capital
Arch Venture Corp
5AM Venture Management
ADAR1 Capital Management
Platinum Investment Mangement
Vanguard Group
Exome Asset Management
BlackRock
Ensign Peak Advisors
BML Capital Management
Ikarian Capital
Geode Capital Management

View all funds holding Q32 Bio